Inhibitory KIR-Ligand Interactions and Relapse Protection Following HLA Matched Allogeneic HCT for AML

Publication/Presentation Date

2020

Department(s)

Department of Medicine, Hematology-Medical Oncology Division

Document Type

Article

Share

COinS